Stock listing

NASDAQ:NEUP Neuphoria Therapeutics Inc. Stock

Home listing (NASDAQ) of Neuphoria Therapeutics Inc.

Follow Neuphoria Therapeutics Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:NEUP

$3.05 USD -0.01 (-0.3%)

Close on Oct 30, 2026

Past year -30.7% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$3.04 – $3.11 USDOct 30, 2026
Volume
70,249 sharesOct 30, 2026
Market cap
$16.50M USDAt the close on Oct 30, 2026 · price × 5.41M shares outstanding
52-week range
$3.03 – $5.53 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$119,153 USDMedian day 21,750 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Neuphoria Therapeutics Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:NEUP · Home$3.05 USD-0.01 (-0.3%)70,249$3.10$3.11$3.04$3.06Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NEUP · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$3.05-0.01-0.3%$3.10$3.11$3.0470,249
$3.06-0.30-8.9%$3.32$3.32$3.03270,085
$3.36-0.03-0.9%$3.40$3.42$3.3216,063
$3.39+0.01+0.3%$3.38$3.39$3.383,638
$3.38-0.06-1.7%$3.39$3.46$3.35526,699
$3.44-0.04-1.1%$3.46$3.59$3.3773,000
$3.480.000.0%$3.46$3.56$3.464,800
$3.48+0.09+2.7%$3.49$3.54$3.4658,800
$3.39+0.08+2.4%$3.365$3.40$3.3320,800
$3.31+0.01+0.3%$3.24$3.41$3.2439,500
$3.30-0.01-0.3%$3.35$3.41$3.2476,000
$3.31+0.07+2.2%$3.25$3.42$3.2518,700
$3.24-0.15-4.4%$3.32$3.37$3.2444,100
$3.39+0.07+2.1%$3.49$3.49$3.3226,600
$3.32-0.04-1.2%$3.32$3.38$3.3210,000
$3.36+0.01+0.3%$3.33$3.41$3.322,500
$3.35-0.07-2.0%$3.40$3.42$3.3416,500
$3.42-0.03-0.9%$3.40$3.45$3.404,500
$3.450.000.0%$3.45$3.50$3.4316,500
$3.45-0.02-0.6%$3.45$3.50$3.4315,500
$3.47-0.04-1.1%$3.51$3.59$3.4512,600
$3.51-0.05-1.4%$3.525$3.54$3.5014,300
$3.56-0.01-0.3%$3.60$3.615$3.5310,400
$3.57-0.08-2.2%$3.64$3.65$3.5715,000
$3.650.000.0%$3.67$3.69$3.652,900
$3.650.000.0%$3.67$3.67$3.651,300
$3.65-0.03-0.8%$3.67$3.70$3.655,400
$3.68-0.055-1.5%$3.69$3.755$3.6615,500
$3.735+0.025+0.7%$3.73$3.77$3.716,700
$3.71+0.01+0.3%$3.69$3.79$3.6817,900
$3.70-0.015-0.4%$3.712$3.83$3.7021,600
$3.715-0.025-0.7%$3.79$3.79$3.715,300
$3.74-0.04-1.1%$3.72$3.81$3.7236,800
$3.78-0.02-0.5%$3.75$3.80$3.7317,700
$3.80+0.07+1.9%$3.78$3.84$3.7412,400
$3.730.000.0%$3.78$3.78$3.7223,000
$3.73-0.02-0.5%$3.79$3.793$3.7043,000
$3.750.000.0%$3.795$3.865$3.7518,600
$3.75-0.02-0.5%$3.84$3.84$3.7222,600
$3.77+0.01+0.3%$3.74$3.78$3.7321,900
$3.76+0.01+0.3%$3.84$3.84$3.7427,300
$3.75-0.04-1.1%$3.84$3.84$3.7517,900
$3.79+0.03+0.8%$3.73$3.81$3.7320,800
$3.760.000.0%$3.71$3.815$3.7152,200
$3.76-0.01-0.3%$3.72$3.835$3.7229,900
$3.77-0.09-2.3%$3.84$3.90$3.7150,100
$3.860.000.0%$3.86$3.995$3.85441,000
$3.86-0.09-2.3%$3.93$3.96$3.8533,600
$3.95+0.04+1.0%$3.90$4.01$3.9057,900
$3.91-0.04-1.0%$3.98$4.05$3.91179,800
$3.95+0.02+0.5%$3.98$4.00$3.9255,700
$3.93-0.05-1.3%$4.03$4.03$3.9323,800
$3.98+0.13+3.4%$3.85$4.34$3.83240,500
$3.85-0.02-0.5%$3.91$3.97$3.78123,000
$3.87+0.04+1.0%$3.83$3.90$3.8023,700
$3.83+0.02+0.5%$3.77$3.88$3.778,900
$3.810.000.0%$3.79$3.87$3.7533,800
$3.81-0.05-1.3%$3.81$3.86$3.8030,400
$3.86+0.04+1.0%$3.81$3.89$3.8115,500
$3.82-0.08-2.1%$3.88$3.98$3.829,600
$3.90-0.05-1.3%$3.92$4.10$3.8329,700
$3.95+0.06+1.5%$3.89$3.99$3.8440,900
$3.89-0.04-1.0%$3.89$3.98$3.8842,000
$3.93+0.05+1.3%$3.86$4.05$3.7557,900
$3.88-0.04-1.0%$3.90$4.00$3.87237,300
$3.92+0.12+3.2%$3.80$4.06$3.7371,000
Ticker
NASDAQ:NEUP
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Neuphoria Therapeutics Inc. news

Decks

Neuphoria Therapeutics Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
8 in the last 12 months · 79 in all · newest Jul 23, 2026 · oldest 2021
Decks
5 decks · latest Jul 24, 2026

Where Neuphoria Therapeutics Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:NEUP · Home listing · This pageNASDAQUnited StatesUSD
BOATS:NEUPBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Neuphoria Therapeutics Inc.